Inventor
DENNY WILLIAM ALEXANDER
NZ50 patents
⚠️ This page may combine multiple inventors who share the name “DENNY WILLIAM ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARNER LAMBERT CO
15 patentsUS6713484B2Mar 30, 2004
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO291 citations99
US6521620B1Feb 18, 2003
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO295 citations99
US6602863B1Aug 5, 2003
Irreversible inhibitors of tyrosine kinases
WARNER LAMBERT CO236 citations98
US6596726B1Jul 22, 2003
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO232 citations98
US6455534B2Sep 24, 2002
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO274 citations98
US6344459B1Feb 5, 2002
Irreversible inhibitors of tyrosine kinases
WARNER LAMBERT CO367 citations98
US6265410B1Jul 24, 2001
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO306 citations98
US6084095AJul 4, 2000
Substituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO292 citations98
US5679683AOct 21, 1997
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO306 citations98
US5654307AAug 5, 1997
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO479 citations98
US5990146ANov 23, 1999
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
WARNER LAMBERT CO92 citations96
US6218388B1Apr 17, 2001
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
WARNER LAMBERT CO37 citations91
US6150359ANov 21, 2000
Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
WARNER LAMBERT CO26 citations91
US7169778B2Jan 30, 2007
Pteridinones as kinase inhibitors
WARNER LAMBERT CO15 citations82
US7786131B2Aug 31, 2010
Pyrimido[5,4-d]pyrimidines derivatives as irreversible inhibitors of tyrosine kinases
WARNER LAMBERT CO6 citations73
AUCKLAND UNISERVICES LTD
13 patentsUS7718688B2May 18, 2010
Nitrobenzindoles and their use in cancer therapy
AUCKLAND UNISERVICES LTD8 citations79
US5872129AFeb 16, 1999
Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
AUCKLAND UNISERVICES LTD12 citations73
US5691371ANov 25, 1997
Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
AUCKLAND UNISERVICES LTD14 citations73
US7776924B2Aug 17, 2010
Nitroaniline-based alkylating agents and their use as prodrugs
AUCKLAND UNISERVICES LTD3 citations61
US6517836B1Feb 11, 2003
Nitrophenylaziridine compounds and their use as prodrugs
AUCKLAND UNISERVICES LTD2 citations61
US7629332B2Dec 8, 2009
Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
AUCKLAND UNISERVICES LTD2 citations58
US7989451B2Aug 2, 2011
Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer treatments
AUCKLAND UNISERVICES LTD4 citations55
US7816521B2Oct 19, 2010
1,2,4-benzotriazine-1,4-dioxides
AUCKLAND UNISERVICES LTD2 citations55
US7064117B2Jun 20, 2006
Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium
AUCKLAND UNISERVICES LTD6 citations55
US7504507B2Mar 17, 2009
Anti-tumour polycyclic carboxamides
AUCKLAND UNISERVICES LTD2 citations53
US7235578B2Jun 26, 2007
Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3H-[ring fused indol-5-yl-(amine-derived)] compounds and analogues thereof, and to products obtained therefrom
AUCKLAND UNISERVICES LTD3 citations53
US11028064B2Jun 8, 2021
Tricyclic heterocyclic derivatives and uses thereof
AUCKLAND UNISERVICES LTD0 citations42
US10239825B2Mar 26, 2019
Ketamine derivatives
AUCKLAND UNISERVICES LTD0 citations28
XENOVA LTD
6 patentsUS5696131ADec 9, 1997
Treatment of cancers
XENOVA LTD10 citations71
US6111109AAug 29, 2000
Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide
XENOVA LTD3 citations59
US6552021B2Apr 22, 2003
Pharmaceutical compounds
XENOVA LTD0 citations51
US5891886AApr 6, 1999
Treatment of cancers
XENOVA LTD1 citations49
US7132419B2Nov 7, 2006
Pharmaceutical compounds
XENOVA LTD0 citations40
US6114332ASep 5, 2000
Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents
XENOVA LTD0 citations35
CANCER RES CAMPAIGN TECH
4 patentsUS6251933B1Jun 26, 2001
Seco precursors of cyclopropylindolines and their use as prodrugs
CANCER RES CAMPAIGN TECH17 citations80
US5985909ANov 16, 1999
Cyclopropylindoles and their seco precursors, and their use as prodrugs
CANCER RES CAMPAIGN TECH14 citations73
US5750782AMay 12, 1998
Nitroaniline derivatives and their use as anti-tumour agents
CANCER RES CAMPAIGN TECH13 citations73
US6124310ASep 26, 2000
Enediyne compounds
CANCER RES CAMPAIGN TECH13 citations72